Evidence map›Paper›PMID 16707577›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2006

Evolution of hepatitis C viral quasispecies and hepatic injury in perinatally infected children followed prospectively.

Patrizia Farci, Isabella Quinti, Stefania Farci, Harvey J Alter, Rita Strazzera, Elvia Palomba, Alessandra Coiana, Daniele Cao, Anna Maria Casadei, Ritarella Ledda and 4 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 73 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Vertical transmission of hepatitis C virus: a tale of multiple outcomes.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2013
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

Patrizia FarciDepartment of Medical Sciences, University of Cagliari, SS 554 Bivio Sestu, 09042 Cagliari, Italy. farcip@pacs.unica.it
Isabella Quinti
Stefania Farci
Harvey J Alter
Rita Strazzera
Elvia Palomba
Alessandra Coiana
Daniele Cao
Anna Maria Casadei
Ritarella Ledda
Raffaele Iorio
Angela Vegnente
Giacomo Diaz
Pier-Angelo Tovo
Federico II University Hospital · ITSapienza University of Rome · ITUniversity of Cagliari · ITUniversity of Turin · ITNational Institutes of Health · US

Funding

Molecular Mechanisms of Pathogenesis of Acute and Chronic Liver DiseasesZIAAI000999 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI FARCI, PATRIZIA · 2009 to 2025
$25.3M
Molecular Mechanisms of Pathogenesis of Chronic Viral HepatitisZ01AI000999 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI FARCI, PATRIZIA · 2007 to 2008
$951k
Study Of Anti-hepatitis C Virus Positive Blood DonorsZ01CL002068 · CLC · CLINICAL CENTER · PI ALTER, HARVEY J · 1992 to 2008
$274k
Viral /Immune Factors That Influence Hepatitis C ProgresZ01CL002078 · CLC · CLINICAL CENTER · PI ALTER, HARVEY J · 1996 to 2008
$137k
A Prospective Study Of Anti-hepatitis C Virus Positive Blood DonorsZIACL002068 · CLC · CLINICAL CENTER · PI DE GIORGI, VALERIA · 2009 to 2025
$0k
Viral And Immune Factors That Influence Recovery Or Progression Of Hepatitis CZIACL002078 · CLC · CLINICAL CENTER · PI DE GIORGI, VALERIA · 2009 to 2025
$0k
6 · The paper itself

Abstract

Perinatal infection with hepatitis C virus (HCV) is characterized by a wide range of alanine aminotransferase (ALT) levels. The mechanisms responsible for this variability are unknown. We examined whether the evolution of the HCV quasispecies was associated with different ALT profiles in perinatally infected children. Sequences within HCV envelope 1 and 2 genes, inclusive of the hypervariable region 1, the viral load, and the nascent humoral immunity were analyzed in serial serum samples from 12 perinatally infected children prospectively followed for a median of 53 months. These patients were selected to represent two different ALT patterns during the first year of life: 6 had high levels (maximum values ranging from 4.2 to 30 times the normal upper limit), and 6 had normal or slightly elevated levels (< 2 times the normal upper limit). Two patterns of viral evolution were identified according to the ALT profiles. Biochemical evidence of hepatic injury was invariably associated with a mono- or oligoclonal viral population, whereas mild or no liver damage correlated with the early emergence of a heterogeneous viral quasispecies. Consistent with selective immune pressure, amino acid changes occurred almost exclusively within the hypervariable region 1 and were temporally associated with antibody seroconversion; at this time, the difference in genetic diversity between the two groups was highly significant (P = 0.002). The two patterns of viral evolution persisted over time and did not correlate with viral load or genotype. Our study demonstrates that, in perinatally infected children, the evolution of HCV quasispecies correlates with hepatic injury. The sequences reported in this paper have been deposited in the GenBank database (accession nos. DQ 504441-DQ 507112).

Indexed as

Biological EvolutionAlanine TransaminaseFemaleHepacivirusHepatitis CHumansInfantInfant, NewbornMaleMolecular Sequence DataAlanine Transaminase

Identifiers

PMID16707577
PMCPMC1482517
OpenAlexW2128993622

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.